Cilostazol vs. Aspirin for recent stroke with brain microbleeds
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial compares two medications—cilostazol and aspirin—to see which is better at preventing another stroke in people who have had a recent clot-caused stroke and also have tiny spots of bleeding in the brain (microbleeds). It aims to find a safer and more effective treatment for this specific group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a stroke caused by a blood clot (not from your heart) within the last month.
- An MRI scan shows tiny spots of old bleeding in your brain, called microbleeds.
- You do not have a condition called cerebral amyloid angiopathy (CAA) that causes brain bleeding.
- You have not had a serious reaction to aspirin or cilostazol before.
- You are not taking a strong blood thinner or need two antiplatelet drugs for more than a month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether the drug cilostazol, when added to your usual aspirin or clopidogrel, can help prevent another stroke. It is being done in Africa and may be a good option if you've recently had a stroke or mini-stroke and want to lower your risk of another one.
This trial tests whether a more intensive dose of a common cholesterol medicine (atorvastatin) increases or decreases the risk of bleeding in the brain for people who have had a stroke and also have tiny brain bleeds. It aims to find the safest and most effective way to use statins in this situation.
This study tests whether a combination of antiplatelet drugs and artery-stabilizing medication can improve recovery after a small stroke caused by damage to tiny blood vessels in the brain. It may help prevent further strokes and support healing.
This trial tests whether the drug cilostazol can help prevent another stroke and slow down damage to the brain's small blood vessels. It may be a good option if you have recently had a small-vessel stroke and have white matter changes on your MRI.
This trial tests whether a combination of two or three anti-platelet medicines (like aspirin, clopidogrel, or cilostazol) is safe and works better than one alone for people who had a stroke from a narrowed artery. The goal is to prevent another stroke.
This study tests whether the drug cilostazol can help prevent another stroke or mini-stroke (TIA) in people who have already had one. It compares adding cilostazol to the standard blood-thinning medicines you and your doctor would normally use.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.